The Henri and Belinda Termeer Center for Targeted Therapies is a pioneer in developing genetically-targeted cancer therapies. The Center is comprised of highly talented investigators and clinicians, active in Mass General Hospital’s 29 treatment programs as well as caring for patients. The Termeer Center’s primary goal is to uncover the underlying causes of cancer and identify new targets for precision oncology.
Give them a fighting chance.
Hope beyond cancer
Leading the way with precision oncology
Pioneering treatment options made possible.
Perfectly placed in the heart of the largest research universe in life sciences, close to Harvard University, MIT, pioneering biotech startups and global pharmaceutical companies, we are able to share our expertise and expand research alliances in a way others can’t, shortening the time it takes to discover and deliver innovative treatments to patients. When our discoveries reveal promising possibilities for treatment, we bring them directly to our patients in the clinic.
With your support, we can make a real difference.
You can be part of the solution.
Every dollar we raise gives helps takes us one step closer to finding solutions, and bringing life-saving treatment to the 22%.
With your help, we are making progress every day, and bring hope to those with the odds stacked against them.